// App-Quantinova.ai

: TIM-3 Expression on CD4+ Bone Marrow T Cells Predicts Relapse of Pediatric B-Precursor Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Franziska Blaeschke

Principal Investigators

  • Semjon Willier

  • Dana Stenger

  • Mareike Lepenies

  • Martin A. Horstmann

  • Gabriele Escherich

  • Martin Zimmermann

  • Theresa Kaeuferle

  • Meino Rohlfs

  • Irene Schmid

  • Michael H. Albert

  • Vera Binder

  • Christoph Klein

  • Tobias Feuchtinger

Medical Centers

  • University Children`s Hospital, Ludwig Maximilians University, Munich, Germany

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany

  • Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

  • Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universitat (LMU), Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved